financetom
Business
financetom
/
Business
/
What's Going On With Salesforce Shares Thursday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Salesforce Shares Thursday?
Aug 29, 2024 11:32 AM

Salesforce, Inc. ( CRM ) shares are roughly flat on Thursday after the company reported better-than-expected second quarter financial results and issued guidance above estimates.

The Details: The company reported adjusted EPS of $2.56 beating analysts estimate of $2.36 and sales of $9.33 billion beating analysts estimate of $9.23 billion. The reported sales figure represents an 8% year-over-year increase.

“We continue to deliver disciplined profitable growth and this quarter, operating margins closed at record highs with GAAP operating margin of 19.1%, up 190 basis points year-over-year, and Non-GAAP operating margin of 33.7%, up 210 basis points year-over year,” said Amy Weaver, president and CFO of Salesforce ( CRM ). 

CFO Resignation: Amy Weaver has decided to resign as president and CFO of the company, however, she will continue to serve as CFO until a replacement is hired. Once a new CFO is hired, Amy will serve as an advisor to Salesforce ( CRM ).

Guidance: Salesforce ( CRM ) issued guidance for the third quarter and the 2025 fiscal year.

Third Quarter: The company sees revenue between $9.31 billion and $9.36 billion versus analyst estimates of $9.23 billion. Salesforce ( CRM ) expects adjusted EPS between $2.42 and $2.44 versus analysts estimate of $2.36.

Fiscal Year: Salesforce ( CRM ) expects revenue from $37.7 billion to $38 billion versus analyst estimates of $37.84 billion.

Analyst Changes: Following the earnings report, multiple analysts raised their price targets on the stock.

See Also: Nvidia Stock Poised For Major $298B Market Jolt As Q2 Earnings Loom, Says Goldman Sachs: ‘Can You Imagine If NVDA Beats Expectations?’

CRM Price Action: At the time of publication, Salesforce ( CRM ) stock is trading 0.38% higher at $259.88, according to data from Benzinga Pro.

Image: Courtesy of Salesforce ( CRM )

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Volkswagen sells 360-million-euro Traton stake for 32.75 euros per share
Volkswagen sells 360-million-euro Traton stake for 32.75 euros per share
Mar 19, 2025
FRANKFURT (Reuters) -Volkswagen said on Wednesday it sold a 2.2% stake in Traton for 360 million euros ($393 million) or 32.75 euros per share for better trading in shares of the commercial-vehicles subsidiary. Volkswagen late on Tuesday said the transaction would enhance the free float and trading liquidity of Traton shares and that Volkswagen would remain a committed and responsible...
India's antitrust raids on global media giants GroupM, Publicis, Dentsu ran through the night
India's antitrust raids on global media giants GroupM, Publicis, Dentsu ran through the night
Mar 19, 2025
* India antitrust raids target GroupM, Interpublic, Dentsu ( DNTUF ), Publicis for price fixing, sources say * Raids continue well past midnight, some officials not allowed to go home * Action coincides with cricket's IPL, a massive advertising event * Potential penalties include up to 10% of turnover By Aditya Kalra NEW DELHI, March 19 (Reuters) - India's antitrust...
Pfizer sells entire Haleon stake for $3.24 billion
Pfizer sells entire Haleon stake for $3.24 billion
Mar 19, 2025
March 19 (Reuters) - Drugmaker Pfizer has sold its entire stake in Haleon ( HLN ) for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal said on Wednesday. ($1 = 0.7708 pounds) (Reporting by Anandita Mehrotra in Bengaluru; Editing by Mrigank Dhaniwala) ...
Rhythm Pharmaceuticals Insider Sold Shares Worth $3,861,272, According to a Recent SEC Filing
Rhythm Pharmaceuticals Insider Sold Shares Worth $3,861,272, According to a Recent SEC Filing
Mar 19, 2025
03:13 AM EDT, 03/19/2025 (MT Newswires) -- Yann Mazabraud, Executive Vice President, Head of International, on March 14, 2025, sold 75,000 shares in Rhythm Pharmaceuticals ( RYTM ) for $3,861,272. Following the Form 4 filing with the SEC, Mazabraud has control over a total of 40,370 common shares of the company, with 40,370 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000110465925025236/xslF345X05/tm259548-1_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved